Al Hammadi Holding Company (TADAWUL: 4007)

Market Cap	6.30B
Revenue (ttm)	1.13B
Net Income (ttm)	326.23M
Shares Out	160.00M
EPS (ttm)	2.04
PE Ratio	19.32
Forward PE	19.45
Dividend	1.40 (3.55%)
Ex-Dividend Date	Nov 18, 2024

Volume	401,393
Open	39.70
Previous Close	39.55
Day's Range	38.95 - 39.70
52-Week Range	38.70 - 71.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 5, 2024

About Al Hammadi Holding Company

Al Hammadi Holding Company, a healthcare group, provides various medical services in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. It engages in the sale of pharmaceutical products. The company was formerly known as Al Hammadi Company For Development and Investment and changed its name to Al Hammadi Holding Company in August 2022. Al Hammadi Holding Company was founded in 1985 and is based in Riyadh, Saudi Arabia.

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1985
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4007

Financial Performance

In 2023, Al Hammadi Holding Company's revenue was 1.18 billion, an increase of 4.84% compared to the previous year's 1.12 billion. Earnings were 303.33 million, an increase of 17.87%.